No association between endogenous LH and pregnancy in a GnRH antagonist protocol: Part I, corifollitropin alfa

Reproductive BioMedicine Online

Volumn 23, Issue 4, 2011, Pages 449-456

  Doody, Kevin J ^a   Devroey, Paul ^b   Leader, Arthur ^c   Witjes, Han ^d   Mannaerts, Bernadette M ^e  

^a Center for Assisted Reproduction   (United States)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c UNIVERSITY OF OTTAWA   (Canada)

^d Biostatistics and Research Decision Sciences   (Netherlands)

^e Global Clinical Research   (Netherlands)

Author keywords

endogenous LH; Engage trial; GnRH antagonist; pregnancy rates

Indexed keywords

CHORIONIC GONADOTROPIN; CORIFOLLITROPIN ALFA; GANIRELIX; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; FEMALE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SINGLE DRUG DOSE;

ADOLESCENT; ADULT; CHORIONIC GONADOTROPIN; FEMALE; FOLLICLE STIMULATING HORMONE; FOLLICLE STIMULATING HORMONE, HUMAN; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZING HORMONE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES;

EID: 80053574886     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2011.06.015     Document Type: Article

References (26)

1. J. Balasch, E. Vidal, J. Peñarrubia, R. Casamitjana, F. Carmona, M. Creus, F. Fábregues, and J.A. Vanrell Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH Hum. Reprod. 16 2001 1636 1643 (Pubitemid 32761742)
2. R.L. Baruffi, A.L. Mauri, C.G. Petersen, V. Felipe, A.M. Martins, J. Cornicelli, M. Cavagna, J.B. Oliveira, and J.G. Franco Jr. Recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-antagonist protocol: a meta-analysis Reprod. Biomed. Online 14 2007 14 25 (Pubitemid 46156558)
3. C. Blockeel, M. De Vos, W. Verpoest, D. Stoop, P. Haentjens, and P. Devroey Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study Hum. Reprod. 24 2009 2910 2916
4. E. Bosch, E. Escudero, J. Crespo, C. Simón, J. Remohí, and A. Pellicer Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome Fertil. Steril. 84 2005 1529 1532 (Pubitemid 41571915)
5. E. Bosch, C. Vidal, E. Labarta, C. Simón, J. Remohí, and A. Pellicer Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists - a randomized study Hum. Reprod. 23 2008 2346 2351
6. E. Bosch, E. Labarta, J. Crespo, C. Simón, J. Remohí, J. Jenkins, and A. Pellicer Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles Hum. Reprod. 25 2010 2092 2100
7. S. Burgués Spanish Collaborative Group on Female Hypogonadotrophic The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain Hum. Reprod. 16 2001 2525 2532 (Pubitemid 34007466)
8. P. Devroey, R. Boostanfar, N.P. Koper, B.M. Mannaerts, P.C. Ijzerman-Boon, B.C. Fauser on behalf of the ENGAGE Investigators A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol Hum. Reprod. 24 2009 3063 3072
9. K. Doody, P. Devroey, K. Gordon, H. Witjes, and B. Mannaerts LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles Reprod. Biomed. Online 20 2010 565 567
10. M.A. Esposito, K.T. Barnhart, C. Coutifaris, and P. Patrizio Role of periovulatory luteinising hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone Fertil. Steril. 75 2001 519 524 (Pubitemid 32175666)
11. M. Filicori, G.E. Cognigni, S. Taraborrelli, D. Spettoli, W. Ciampaglia, and C. Tabarelli de Fatis Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea Fertil. Steril. 72 1999 1118 1120
12. M. Filicori, G.E. Cognigni, E. Gamberini, L. Parmegiani, E. Troilo, and B. Roset Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation Fertil. Steril. 84 2005 394 401 (Pubitemid 41125260)
13. R. Fleming, F. Lloyd, M. Herbert, J. Fenwick, T. Griffiths, and A. Murdoch Effects of profound suppression on luteinising hormone during ovarian stimulation follicular activity, oocyte, and embryo function in cycles stimulated with purified follicle stimulating hormone Hum. Reprod. 13 1998 1788 1792
14. G. Griesinger, A. Schultze-Mosgau, K. Dafopoulos, A. Schroeder, S. von Otte, D. Hornung, K. Dietrich, and R. Felberbaum Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol Hum. Reprod. 20 2005 1200 1206 (Pubitemid 40790242)
15. G. Griesinger, D.B. Shapiro, E.M. Kolibianakis, H. Witjes, and B.M. Mannaerts No association between endogenous LH and pregnancy in a GnRH antagonist protocol with: part II, recombinant FSH Reprod. Biomed. Online 23 2011 457 465
16. J.A. Huirne, A.C. van Loenen, R. Schats, J. McDonnell, P.G. Hompes, J. Schoemaker, R. Homburg, and C.B. Lambalk Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy Hum. Reprod. 20 2005 359 367 (Pubitemid 40277602)
17. P. Humaidan, L. Bungum, M. Bungum, and C.Y. Andersen Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation Hum. Reprod. 17 2002 2016 2021
18. E.M. Kolibianakis, K. Zikopoulos, J. Schiettecatte, J. Smitz, H. Tournaye, M. Camus, A.C. Van Steirteghem, and P. Devroey Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF Hum. Reprod. 19 2004 2490 2496 (Pubitemid 39481272)
19. P. Merviel, J.M. Antoine, E. Mathieu, F. Millot, J. Mandelbaum, and S. Uzan Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer Fertil. Steril. 82 2004 119 125 (Pubitemid 38968786)
20. H.J. Out, A. Rutherford, R. Fleming, C.C.K. Tay, G. Trew, W. Ledger, and D. Cahill A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction Hum. Reprod. 19 2004 90 95 (Pubitemid 38072013)
21. J. Smitz, A.N. Andersen, P. Devroey, and J.C. Arce Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients Hum. Reprod. 22 2007 676 687
22. B. Tarlatzis, E. Tavmergen, M. Szamatowicz, A. Barash, A. Amit, E. Levitas, and Z. Shoham The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study Hum. Reprod. 21 2006 90 94 (Pubitemid 41794295)
23. The European Recombinant Human LH Study Group Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study J. Clin. Endocrinol. Metab. 83 1998 1507 1514
24. The Ganirelix Dose-finding Study Group A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon) Hum. Reprod. 13 1998 3023 3031
25. M.H. van der Gaast, M.J. Eijkemans, J.B. van der Net, E.J. de Boer, C.W. Burger, F.E. van Leeuwen, B.C. Fauser, and N.S. Macklon Optimum number of oocytes for a successful first IVF treatment cycle Reprod. Biomed. Online 13 2006 476 480 (Pubitemid 44548781)
26. L.G. Westergaard, S.B. Laursen, and C.Y. Andersen Increased risk of early pregnancy loss by profound suppression of luteinising hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction Hum. Reprod. 15 2000 1003 1008 (Pubitemid 30251290)